Rankings
▼
Calendar
RNA Q1 2024 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+58.7% YoY
Gross Profit
$3M
81.9% margin
Operating Income
-$77M
-2178.6% margin
Net Income
-$69M
-1943.4% margin
EPS (Diluted)
$-0.79
QoQ Revenue Growth
+61.6%
Cash Flow
Operating Cash Flow
-$70M
Free Cash Flow
-$71M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$951M
Total Liabilities
$121M
Stockholders' Equity
$831M
Cash & Equivalents
$471M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$2M
+58.7%
Gross Profit
$3M
-$46M
+106.4%
Operating Income
-$77M
-$58M
-34.0%
Net Income
-$69M
-$52M
-31.4%
← FY 2024
All Quarters
Q2 2024 →